Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN).
Latest Information Update: 14 Nov 2015
Price :
$35 *
At a glance
- Drugs Amitriptyline/ketamine (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms ATTRACT-CPN
- 09 Jun 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 13 Sep 2013 Planned end date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 01 Feb 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.